ABMC Stock Analysis

American Bio Medica Corp - Real-time stock metrics, market data, and comprehensive analysis

Loading...

Fetching stock data...

American Bio Medica Corp

American Bio Medica Corporation develops, manufactures and sells immunoassay tests for the immediate, point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. The Company's DOA testing products offer employers, law enforcement, government, health care, laboratory and education professionals, self-contained products capable of identifying illicit drug use within minutes. In addition to the manufacture and sale of DOA testing products, it provides bulk test strip contract manufacturing services for other POCT companies.

Market Data

Current Price

$0.00

+$0.00 (0.00%)
Market Cap

-

Total Company Value
Day Range
$0.00 - $0.00
Session Volume
-
Shares traded today

Valuation Metrics

P/E Ratio

-

Price ÷ Earnings
EPS (Basic)

-

Earnings Per Share
Price-to-Book

-

Market Value ÷ Book Value

Financial Health

Revenue (TTM)

-

Trailing 12 Months
Net Income (TTM)

-

Profit After Tax
Gross Margin

-

Revenue Efficiency

Returns & Dividends

Dividend Yield

-

Annual Dividend ÷ Price
Annual Dividend

-

Per Share
Payout Ratio

-

Dividend ÷ EPS

Price Performance

Price Chart
All times are in Eastern Time (ET)

Recent News

No news available

Data Source: Financial data is sourced from SEC filings via Tiingo and may be delayed. Market Status: OPEN - Prices update every 2 minutes. (Last updated: 2:22 PM)
Logos provided by Logo.dev

Contact Me

Have a question or want to work together? Fill out the form below and we’ll get back to you as soon as possible.

Contact Form Demo

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.